Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis
· thehindubusinessline.com
Pfizer surpasses profit expectations in Q2, driven by strong Eliquis sales, reporting 77 cents per share versus 68 cents expected.
Pfizer beat Wall Street estimates for second-quarter profit on Tuesday, driven by strong demand for its blood thinner, Eliquis.
On an adju...